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Chlamydia trachomatis (Ct) can induce scarring disease of the ocular mucosa, known as
trachoma, the most common infectious cause of blindness worldwide. We hypothesized
that epithelial-mesenchymal transition (EMT) contributes to the fibrotic process in
trachomatous scarring. Infection of human conjunctival epithelial cells (HCjE) with Ct
activated signaling pathways involved in EMT induction, which was correlated with
decreased expression of E-cadherin, guardian of the epithelial phenotype. In addition, Ct
infection was associated with increased expression of two mesenchymal cell markers:
fibronectin and α-SMA. The DNA methylation statuses of selected regions of E-cadherin,
fibronectin, and α-SMA genes revealed that Ct infection was accompanied with changes
in DNA methylation of the E-cadherin promoter, while the expression of the two
mesenchymal markers was not related with this epigenetic event. Our data suggest that
Ct infection of conjunctival epithelial cells induces EMT-like changes that go along with
modification of the methylation profile of the E-cadherin promoter and could, as one of
the earliest events, contribute to processes triggering conjunctival scarring.
Keywords: Chlamydia trachomatis, human conjunctival epithelial cells, HCjE, epithelial-mesenchymal transition
(EMT), DNA methylation, E-cadherin
INTRODUCTION
Trachoma is the most common cause of preventable blindness from infectious origin worldwide
(Taylor et al., 2014). An estimated 200 million people live in endemic areas and are at risk of
developing trachoma-related blindness (WHO, 2014, 2016). The disorder is triggered by ocular
infection with ocular strains ofChlamydia trachomatis (Ct) via direct smear infection ormechanical
transmission (Solomon et al., 2004; Wright et al., 2008). Conjunctival infection (often repeated)
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precedes chronic inflammation and eventually leads to
conjunctival fibrosis (Whittum-Hudson et al., 1986; Hu
et al., 2013). The resulting scarring is the key element in the
development of the blinding sequelae leading to inversion of
the eyelids and lashes (trichiasis) that wound the ocular surface
(Mohammadpour et al., 2016). Chronic keratoconjunctivitis
and/or prolonged trichiasis cause corneal opacification and
blindness (Mabey et al., 2003; Brunham and Rey-Ladino, 2005;
Wolle et al., 2009). Like in any fibrotic process, it is believed that
the scar tissue in trachoma originates from activated fibroblasts
(Kechagia et al., 2016), and there is supporting evidence that
innate and adaptive immunity involved in the resolution of
Ct infection may initiate the fibrotic process (Brunham and
Rey-Ladino, 2005). Thus, to date, research has been focused
on elucidating the fibroblast-stimulating profibrotic mediators.
Only recently, an alternative pathway, the process of epithelial-
mesenchymal transition (EMT), was proposed to be involved in
the development of end-stage trachoma (Derrick et al., 2015).
EMT consists of a series of events constituting reversible
transition of epithelial into mesenchymal cells. During EMT, cells
lose their epithelial characteristics, such as apical-basal polarity
and cell–cell junctions, and acquire mesenchymal features,
including front-back polarity, enriched cell–matrix interactions,
and motility. Changes in cell morphology and function during
EMT can be traced through numerous markers established in
in vitro models of EMT where complete transition from the
epithelial to the mesenchymal state is observed (Zeisberg and
Neilson, 2009). However, data from in vivo studies indicated that
EMT comprises a whole spectrum of intermediary, transitional
states between the epithelial and the mesenchymal phenotype
(Nieto et al., 2016). In fact, the presence of intermediary epithelial
and mesenchymal phenotypes had been observed in most of the
EMT-related processes and marked as “EMT-like,” “incomplete,”
or “partial” EMT (Jordan et al., 2011; Morbini et al., 2011;
Grigore et al., 2016). EMT has several triggers, which all act
via different pathways. TGFβ family members are considered
the main inducers of EMT. TGFβ signaling results in the
activation of either SMAD transcription factors in the canonical
pathway, or activation of PI3K-AKT and MAP kinases in the
non-canonical pathway (Miyazono, 2009). These kinases also
activate downstream tyrosine kinase receptors (RTKs), through
which the other growth factors act (Lamouille et al., 2014).
Another major signaling pathway involved in EMT is the Wnt
pathway, which involves inhibition of GSK3β and consequent
induction of β-catenin-regulated gene expression (Niehrs, 2012).
Besides soluble ligands, it has been shown that components of
the extracellular matrix (ECM) are important for EMT induction
through integrin receptors (Chen et al., 2013). The activation of
different EMT-inducing pathways and their intensive crosstalk
result in the induction and activation of the same set of EMT-
related transcription factors (ZEB, SNAIL, and TWIST) and the
expression of common EMT marker genes. Thus, decreased
expression of E-cadherin, a cell–cell adhesion molecule that is
highly expressed in epithelial cells, has become a hallmark of the
EMT process (Zeisberg and Neilson, 2009). A frequently used
mesenchymal EMT marker is increased α-SMA expression, as
it appears de novo in response to tissue injury, partially as a
result of the EMT process. In addition, fibronectin, a glycoprotein
responsible for cellular interactions with the ECM, is of particular
interest, as its expression increases during EMT, and it has been
shown to be one of the EMT inducers through integrin signaling
(Kim et al., 2006).
EMT is regulated at the transcriptional, posttranscriptional
(through miRNA and alternative splicing), and posttranslational
(through numerous stability- and activity-affecting protein
modifications) levels. Recent findings have suggested that
epigenetic events are master regulators of expression of all EMT-
related genes (Tam and Weinberg, 2013; Serrano-Gomez et al.,
2016). The effect of DNA methylation on gene expression has
been shown for several EMT marker genes (Lombaerts et al.,
2006; Hu et al., 2010), while the overall significance of DNA
methylation for EMT was confirmed by DNA methylomes of
cells undergoing EMT, which revealed that changes in DNA
methylation of both promoters and gene bodies are dynamic
and reversible and are strongly associated with transcriptional
regulation of EMT-related genes (Carmona et al., 2014).
Possible factors giving rise to conjunctival fibrosis are
infection/inflammation, trauma, potential co-infections, dust,
and genetics. Various bacteria and viruses are known to induce
epigenetic changes in host cells (Minarovits, 2009; Paschos
and Allday, 2010; Niller and Minarovits, 2016), prompting
researchers to speculate that Ct might directly influence
epigenetic mechanisms involved in EMT processes in trachoma
(Derrick et al., 2015). In genital models, Igietseme et al. (2015)
were able to show that Ct infection per se induced EMT in
vitro and in vivo, which was associated with altered expression
of crucial miRNAs that control EMT and fibrosis. Nevertheless,
the underlying mechanisms by which Ct might induce the
development of fibrosis have not been fully elucidated.
The aim of this study was to test the ability of Ct to induce
EMT-related processes in human conjunctival epithelial (HCjE)
cells in vitro by analyzing the expression of selected relevant EMT
inducers and marker genes (E-cadherin, fibronectin, α-SMA),
and to investigate whether alterations in gene expression after
Ct infection correlate with changes in their DNA methylation
profiles and subsequent gene expression. The involvement of
epigenetic mechanisms in EMT process in trachoma would open
up possibilities for novel therapeutic approaches in trachoma
treatment.
MATERIALS AND METHODS
Infection of HCjE Cells with Ct
All experiments involving biohazards (Ct and cell lines) or
hazardous chemicals were carried out using standard protective
measures and following all local and national regulations.
Stocks of Ct (serovar B/HAR-36, ATCC R© VR-573TM) were
grown in McCoy cells (ATCC R© CRL-1696TM) according to
standard procedures (Rank et al., 1988). Briefly, confluent
cultures of McCoy cells were inoculated at an multiplicity of
infection (MOI) of 10 in 75-cm2 tissue culture flasks, centrifuged
at 900 × g for 1 h, and incubated for 48 h in the presence of
1 µg/ml cycloheximide (Sigma, Steinheim, Germany). The cells
were disrupted with glass beads and centrifuged at 900 × g for
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15 min to remove host cell debris. Inoculation stocks and McCoy
cells were tested to be negative for mycoplasma.
hTert-immortalized HCjE cells, kindly provided by Prof.
Ilene Gipson (Schepens Eye Research Institute, Harvard Medical
School, Boston), were maintained in keratinocyte serum-
free medium (Life Technologies, Paisley, UK) supplemented
with bovine pituitary extract, 0.2 ng/mL recombinant human
epidermal growth factor, 0.4 mM CaCl2, and 1000 U/mL
penicillin and 1000 µg/mL streptomycin (GE Healthcare,
South Logan, UT, USA) at 37◦C, under 5% CO2 and 95%
humidity. The medium was changed every second day, and the
cells were passaged at 70% confluence. Cells were harvested
by trypsinization (0.05% trypsin/0.02% EDTA in PBS, GE
Healthcare) and seeded at a density of 400,000 cells/flask in
75-cm2 flasks. Confluent cultures (an estimated 3.5 × 106
HCjE cells) were infected with 107 infectious units (IFU) Ct in
inoculation medium (DMEM/Ham’s F-12 1:1, Life Technologies)
per flask and the MOI was calculated to be 3. To promote
adhesion, the flasks were centrifuged at 900 ×g for 1 h at 37◦C.
After incubation for 1 h at 37◦C, the inoculation medium was
changed to keratinocyte serum-free medium without antibiotics,
and the cells were incubated for another 72 h. Host cell viability
was monitored by lactate dehydrogenase assay and immunoblot
analysis for PARP-1, procaspase 3, and active form of caspase 3;
no differences were observed between control and Ct-infected
cells.
Isolation of DNA, RNA, and Proteins
Cells were harvested by scraping and pelleted at 900 ×g.
For isolation of DNA, RNA, and proteins, an AllPrep
DNA/RNA/Protein Mini Kit (Qiagen, Hilden, Germany) was
used according to the manufacturer’s instructions. Samples were
stored at−80◦C until analysis.
Quantitative Reverse-Transcription PCR
(qRT-PCR)
Reverse transcription was carried out with the RevertAid First
Strand cDNA Synthesis Kit (Fermentas, Burlington, Canada)
on 1 µg DNAse I-treated RNA, using oligo(dT) primers. qRT-
PCR was carried out using Maxima SYBR Green/ROX qPCR
Master Mix (Fermentas) on a QuantStudio 3 Real-Time PCR
system (Applied Biosystems, Carlsbad, CA, USA). The thermal
cycles used were as follows: initial denaturation at 95◦C/10 min
and 40 cycles of two-step PCR at 95◦C/15 s and 57◦C/60 s (all
genes except SNAI1 and ZEB2) or 60◦C/60 s (SNAI1 and ZEB2).
The relative expression levels of target genes were calculated
using the comparative 2−11Ct method after normalization using
GAPDH as an endogenous control, as no difference in GAPDH
mRNA expression between control and Ct-infected HCjE cells
was observed.
Primers were designed with Primer-BLAST
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/) using
sequences stored in GenBank under the following accession
numbers: TGFβ1 (transforming growth factor beta 1)
NM_000660; TGFβ2 (transforming growth factor beta 2)
NM_003238; CDH1 (cadherin 1) NM_004360; FN1 (fibronectin
1) NM_212482; ACTA2 (actin, alpha 2, smooth muscle, aorta;
α-SMA) NM_001141945; SNAI1 (snail family transcriptional
repressor 1) NM_005985; ZEB2 (zinc finger E-box binding
homeobox 2) NM_014795; GAPDH (glyceraldehyde-3-
phosphate dehydrogenase) NM_002046. The primer sequences
are listed in Table S1 (Supplemental Information).
Immunoblot Analysis
Equal amounts of cell lysates were separated by 12% sodium
dodecyl sulfate polyacrylamide gel electrophoresis and
transferred onto polyvinylidene difluoride membranes.
Immunoblot analysis was conducted using antibodies listed
in Table S2 (Supplemental Information). All primary antibodies
were incubated overnight at 4◦C, followed by incubation with
the appropriate horseradish peroxidase-conjugated secondary
antibody at room temperature for 1 h. Blots were stained using
chemiluminescence according to the manufacturer’s instructions
(Amersham Pharmacia Biotech, Amersham, UK). Membranes
were stripped and reprobed with anti-GAPDH antibody as a
loading control. Signal intensities were analyzed using TotalLab
ver. 1.10 electrophoresis software (Phoretix International Ltd,
Newcastle upon Tyne, UK) and normalized to GAPDH as an
internal control, as no difference in GAPDH protein expression
between control and Ct-infected cells was observed.
Immunocytochemistry
Cells were grown on sterile glass coverslips in 24-well tissue
culture plates and infected with 105 IFU Ct per well. Infection
was carried out as described above. After 72 h, the cells
were fixed with 4% paraformaldehyde (Science Services GmbH,
Munich, Germany) in PBS for 15 min at 37◦C. The cells
were permeabilized with PBS containing 0.3% Triton X-100
for 10 min and blocked with 3% bovine serum albumin
for 1 h. The coverslips were incubated overnight at 4◦C
with primary antibodies listed in Table S2 and diluted in
PBS containing 0.2% Tween-20. For acquiring fluorescent
signal, the slides were incubated overnight at 4◦C with
fluorescently labeled secondary antibodies listed in Table S2.
All washes were done in PBS-Tween-20 0.2% (v/v). DNA
was visualized by adding 4,6-diamidino-2-phenylindole (DAPI)
(Roche Diagnostics, Mannheim, Germany) (0.2 µg/mL) for 20
min. The cover slips were mounted on glass slides with Mowiol
(Calbiochem, San Diego, CA, USA) and images were taken with
an Axiocam digital camera attached to the Axio Observer Z1
microscope (Carl Zeiss Microscopy GmbH, Jena, Germany),
using appropriate filters.
DNA Methylation Analysis
Bisulfite Conversion of DNA
Genomic DNA isolated from control and Ct-infected cells
was bisulfite-converted using the EZ-DNA methylation kit
(D5002; Zymo Research, Orange, CA, USA) according to
manufacturer’s instructions. CpG islands (short stretches of
DNA in which the frequency of CG dinucleotides is higher
than in other regions) were predicted using CpG Island
Searcher (http://cpgislands.usc.edu/) (Takai and Jones, 2003)
with standard parameters (%GC, 55; Obs CpG/Exp CpG,
0.65; Length, 500 bp; Distance, 100 bp). Genomic DNA
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sequences that were uploaded for analysis encompassed the
regions 3,000 bp upstream and 3,000 bp downstream from
the transcription start site (TSS) (marked as +1) of the E-
cadherin (CDH1; NCBI ref. sec. NG_008021.1), fibronectin
(FN1; NG_012196.1), and α-SMA (ACTA2; NG_011541.1)
genes. All primer pairs, methylated and unmethylated, for
DNA methylation analysis were designed in MethPrimer
(http://www.urogene.org/cgi-bin/methprimer/methprimer.cgi)
and are listed in Table S3 (Supplemental Information).
Methylation-Specific PCR (MSP)
MSP analysis was conducted using methylated (M) primers
containing two CpGs in each primer (forward and reverse) for
CDH1, and one CpG in forward and two CpGs in reverse primers
for FN1 and ACTA2. The reaction mixture for MSP contained
Maxima SYBR Green/ROX qPCR Master Mix (Fermentas), 4
µL of bisulfite-converted DNA (theoretical concentration of 60
ng/µL), and 0.5µMofMprimers in a final volume of 10µL.MSP
was conducted on the QuantStudio 3 Real-Time PCR system.
PCR cycling conditions were as follows: initial denaturation
step at 95◦C/10 min followed by 40 cycles of denaturation at
95◦C/15 s and annealing and elongation at 58◦C/60 s for CDH1
and FN1 or 55◦C/60 s for ACTA2. Reference primers, which do
not contain CpGs and exclusively amplify bisulfite-converted
DNA, were used as an endogenous control for normalization of
the MSP results and as a control for efficient bisulfite conversion.
After normalization, the amount of the methylated product
was estimated in comparison to in vitro methylated DNA,
bisulfite-converted and amplified under the same conditions,
which was assumed to be 100% methylated. In vitro methylation
was performed using CpG Methylase M.SssI (E2011) (Zymo
Research, Orange, CA, USA), which completely methylates all
cytosine residues.
Methylation-Sensitive High-Resolution Melting
(MS-HRM)
Human methylated and non-methylated DNA standards
(D5014) (Zymo Research) were bisulfite-converted according
to manufacturer’s instructions. To generate a range of
methylated:non-methylated DNA standards, methylated
and non-methylated templates were mixed at 0:100, 25:75, 50:50,
and 100:0 ratios. PCR amplification and MS-HRM analysis
were carried out sequentially on a QuantStudio 3 Real-Time
PCR system. Multiplex PCR with a mix of all four primers (M
and unmethylated, U) was used to cover all possible variants
in methylation status. PCR was carried out in a 10-µL reaction
mixture consisting of 5 µL 2× MeltDoctor HRM Master Mix
(Applied Biosystems), 0.15 µM of each primer, and 1 µL
bisulfite-converted template (theoretical concentration of 20
ng/µL). The amplification consisted of initial denaturation at
95◦C/10 min, followed by 45 cycles of three-step PCR and a final
elongation step at 72◦C/7 min. The three-step PCR program
consisted of 5 cycles of denaturation at 95◦C/30 s, annealing at
58◦C/30 s and elongation at 72◦C/60 s; 5 cycles of denaturation
at 95◦C/30 s, annealing at 53◦C/30 s and elongation at 72◦C/60
s; and 35 cycles of denaturation at 95◦C/30 s, annealing at
47◦C/30 s and elongation at 72◦C/60 s. The HRM program
consisted of temperature ramping from 60–95◦C by 0.025◦C/s
with florescence acquisition at each temperature increment.
HRM Software v3.1 (Applied Biosystems) was employed for
end-product analysis. Peak heights of standards, obtained from
difference curves aligned against an unmethylated control
(0%), were plotted against the percentage of methylation to
obtain a standard curve and linear regression equation. After
normalization, the degree of methylation of each sample was
quantitatively calculated from the linear regression equation.
Bisulfite Sequencing
Bisulfite-modified DNA was amplified using M primers in a
30-µL reaction mixture that included 15 µL 2× AmpliTaq
Gold 360 Master Mix (Applied Biosystems), 0.5 µM of each
primer, and 4 µL of bisulfite-converted template (theoretical
concentration of 80 ng/µL). Amplification was carried out on an
Eppendorf Mastercycler Pro (Eppendorf Austria GmbH, Vienna,
Austria), using the following thermal cycles: initial denaturation
at 95◦C/10 min, 45 cycles of three-step PCR, and final elongation
at 72◦C/7 min. The three-step PCR program consisted of 5
cycles of denaturation at 95◦C/30 s, annealing at 62◦C/30 s and
elongation at 72◦C/60 s; 5 cycles of denaturation at 95◦C/30
s, annealing at 57◦C/30 s and elongation at 72◦C/60 s; and 35
cycles of denaturation at 95◦C/30 s, annealing at 51.5◦C/30 s
and elongation at 72◦C/60 s. Purification of PCR products and
Sanger sequencing of bisulfite-converted DNA were carried out
by Eurofins Genomics AT (Vienna, Austria). The sequencing
results were analyzed using the BiQ Analyzer software (Max
Planck Institute for Informatics, Saarbrücken, Germany).
Statistical Analysis
Experiments were performed in triplicate and all results are
presented as the mean ± SD. IBM SPSS Statistics for Windows,
Version 20.0 (Armonk, NY, USA) was used for statistical analysis.
The Shapiro–Wilk test was used to determine whether samples
followed normal distribution. For normally distributed data, two
groups were compared using Student’s t-test. For data with non-
normal distribution, the Mann–Whitney U test was applied.
The null hypothesis was rejected at p < 0.05. “∗” Indicates
statistically significant difference compared to control cells (∗p<
0.05; ∗∗p< 0.01).
RESULTS
Ct Infection Triggers EMT-Inducing
Signaling Pathways
First, we tested the hypothesis that infection of HCjE with Ct
induces changes in expression profiles of proteins that could
trigger a transition of the conjunctival epithelium toward a
mesenchymal state, thus contributing to trachomatous scarring.
To this end, we analyzed the expression of two TGFβ genes,
known as main EMT inducers, using qRT-PCR (Figure 1A).
Both TGFβ genes were significantly upregulated upon infection
with Ct; TGFβ1 and TGFβ2 showed a 2- and 7-fold increase
in mRNA, respectively. Besides TGFβ proteins, EMT can be
induced through several other stimuli, which all act via different
pathways (overview presented in Figure 1B). The presence
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FIGURE 1 | Ct Infection Triggers EMT-inducing Signaling Pathways. (A) mRNA levels of TGFβ1 and TGFβ2 in control (C) and HCjE cells infected with 107 IFU of Ct
(Ct) as determined by qRT-PCR. mRNA levels are relative to GAPDH and are expressed as means ± SDs. (B) Overview of signaling pathways involved in EMT
induction and the presence of key components as determined by immunoblot analysis in control (C) and HCjE cells infected with 107 IFU of Ct. Quantitative results of
at least three immunoblots are presented. The graph depicts changes in phosphoprotein levels relative to the corresponding non-phosphorylated proteins, after
normalization to GAPDH, which was used as loading control. The results are expressed as means ± SDs. (C) mRNA levels of SNAIL1 and ZEB2 in control (C) and
HCjE cells infected with 107 IFU of Ct as determined by qRT-PCR. mRNA levels are relative to that of GAPDH and are expressed as means ± SDs.
and/or activation of some of the main downstream factors in
the EMT-inducing network were determined by immunoblot
analysis. Infection of HCjE cells with Ct resulted in a statistically
significant increase in phosphorylation of JNK, p38, and ERK1/2,
suggesting the activation of MAP kinases downstream of
TGFβ receptors and RTKs. Activation of the canonical TGFβ
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FIGURE 2 | E-cadherin is Downregulated in Response to Ct Infection. (A) mRNA expression levels of CDH1 in control (C) and HCjE cells after infection with 107 IFU of
Ct (Ct) as determined by qRT-PCR. mRNA levels are relative to that of GAPDH and are expressed as means ± SDs. (B) Protein levels of E-cadherin in control (C) and
Ct-infected HCjE cells (Ct) as determined by immunoblot analysis using anti-E-cadherin antibody. Quantitative results of three immunoblots are presented, where
E-cadherin protein levels are relative to the level of GAPDH, which was used as loading control. The results are expressed as means ± SDs. (C) Immunofluorescence
analysis of control and Ct-infected HCjE cells with anti-E-cadherin antibody (light orange fluorescence). Nuclei are stained with DAPI (blue fluorescence).
pathway was suggested by a significant rise in phosphorylated
Smad3. HCjE cells responded to Ct infection by augmented
GSK3β-inhibitory phosphorylation and activation of PI3K/AKT,
suggesting involvement of Wnt and integrin signaling. As EMT-
inducing signaling pathways converge to the upregulation of
specific EMT-related transcription factors, the increased mRNA
expression of SNAIL1 and ZEB2, (Figure 1C), additionally
supported the possibility of EMT promotion in HCjE cells after
infection with Ct.
E-Cadherin Is Downregulated in Response
to Ct Infection
As 72 h of infection of HCjE cells with Ct did not induce
morphological change, but did trigger EMT-induced signaling,
we next aimed to investigate whether Ct infection leads to EMT-
related gene expression changes in HCjE cells, and to what extent.
To this end, the mRNA and protein expression levels of E-
cadherin were examined. Infection with Ct significantly reduced
CDH1 expression; the CDH1 mRNA level was 2.7-fold higher in
control than in Ct-infected HCjE cells (Figure 2A). Accordingly,
E-cadherin protein was diminished 1.8-fold after Ct infection
as revealed by immunoblotting (Figure 2B). Downregulation
of E-cadherin after Ct infection was visualized and confirmed
by immunocytochemistry; a marked loss of positive staining
at cell–cell contacts after infection with Ct was observed
(Figure 2C).
Ct Infection Is Accompanied by
Upregulation of Mesenchymal Markers
α-SMA and Fibronectin
Next, we examined the effects of Ct infection on the expression
levels of two mesenchymal markers, fibronectin and α-SMA,
in HCjE cells (Figures 3, 4, respectively). FN1 mRNA showed
a statistically significant 3.3-fold increase (Figure 3A), while
ACTA2 mRNA was increased 1.3-fold in Ct-infected cells
as compared to control cells (Figure 4A). Immunoblotting
revealed 2.3- and 2.8-fold increases in fibronectin (Figure 3B)
and α-SMA (Figure 4B), respectively, upon Ct infection.
Immunocytochemistry with anti-fibronectin (Figure 3C) and
anti-α-SMA antibodies (Figure 4C) confirmed the upregulation
of both mesenchymal markers.
DNA Methylation Status of CDH1, FN1, and
ACTA2 after Ct Infection
To assess whether the observed changes in expression of
the selected EMT markers are associated with altered DNA
methylation of the corresponding genes, DNA methylation
patterns of selected regions in the promoters and gene bodies
of CDH1, FN1, and ACTA2 were examined with MSP, MS-
HRM, and bisulfite sequencing. The CDH1 gene contains one
large (1,735 bp) CpG island that covers the region from
−406 to +1,329 with regard to the position of the TSS. The
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FIGURE 3 | Mesenchymal Marker Fibronectin is Upregulated in Response to Ct Infection. (A) mRNA expression levels of FN1 in control (C) and HCjE cells after
infection with 107 IFU of Ct (Ct) as determined by qRT-PCR. mRNA levels are relative to GAPDH and are expressed as means ± SDs. (B) Protein levels of fibronectin
in control (C) and Ct-infected HCjE cells (Ct) as determined by immunoblot analysis using anti-fibronectin antibody. Quantitative results of three immunoblots are
presented, where fibronectin protein levels are relative to the level of GAPDH, which was used as loading control. The results are expressed as means ± SDs.
(C) Immunofluorescence analysis of control and Ct-infected HCjE cells with anti-fibronectin antibody (light orange fluorescence). Nuclei are stained with DAPI (blue
fluorescence).
region selected for DNA methylation analysis encompasses the
promoter sequence and TSS, and its genomic position, as well as
those of the primers used in this study, is shown in Figure 5A.
Ct infection initiated a 4% increase in DNA methylation, from
11.5% in control to 15.5% in Ct-infected cells (Figure 5B). The
use of HRM allowed us to estimate the overall change in DNA
methylation in the selected region (Figures 5C–F). HRM data
revealed an increase from 12.8 to 21.8% after Ct infection,
suggesting that the CDH1 promoter region undergoes alterations
in DNA methylation in HCjE cells as a result of Ct infection.
To specify particular CpGs that are differentially methylated in
control and Ct-infected cells, the selected region was subjected to
bisulfite sequencing. Figure 6A shows the results of four samples.
The sequenced region encompasses 12 CpGs (aside from CpGs
positioned in primers), eight of which are in close proximity to
the TSS. Of these, seven showed an increase in methylation level
in Ct-infected cells. Moreover, methylation statuses at positions
−57, −103, and −105 changed from 25% of methylation to fully
methylated (100%) after Ct infection (Figure 6B).
The FN1 gene contains one large CpG island (1,403 bp)
located at –635 to +360 from the TSS. We selected a region
within the gene body (first exon) for DNA methylation analysis.
Positions of the selected region and primers are presented in
Figure 7A. MSP analysis showed that approximately 5% of
DNA from control HCjE cells was methylated in CpG positions
located within the primer positions. However, after infection with
Ct, these CpG positions were almost completely unmethylated
(0.5% of methylation) (Figure 7B). HRM analysis revealed the
same trend; DNA methylation decreased from 13.5% in control
to 10.5% in Ct-infected HCjE cells (Figures 7C–F). However,
we could not detect any difference in DNA methylation of
FN1 between control and Ct-infected HCjE cells by bisulfite
sequencing, as the only methylated CpGs were positioned in
primer sequences, while the other CpGs were all unmethylated
in both samples (data not shown). Therefore, the MSP results
reflect a precise quantification of changes in DNA methylation
of the selected region. Based on theMSP and HRM data, it can be
concluded that slight demethylation of 3–4% of the selected DNA
region in FN1 accompanies Ct infection.
The ACTA2 gene contains a CpG island located at –289 to
+883 from the TSS. The region that was selected for DNA
methylation analysis of ACTA2 is located in the gene body
(first exon), as shown in Figure 8A. MSP analysis revealed 10%
diminished DNA methylation at CpG positions located within
the primer positions in infected HCjE cells (Figure 8B). HRM
analysis confirmed that infection of HCjE cells with Ct results
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 June 2017 | Volume 7 | Article 253
Rajic´ et al. Chlamydia trachomatis Infection Triggers EMT
FIGURE 4 | Mesenchymal Marker α-SMA is Upregulated in Response to Ct Infection. (A) mRNA expression levels of ACTA2 in control (C) and HCjE cells after
infection with 107 IFU of Ct (Ct) as determined by qRT-PCR. mRNA levels are relative to that of GAPDH and are expressed as means ± SDs. (B) Protein levels of
α-SMA in control (C) and Ct-infected HCjE cells (Ct) as determined by immunoblot analysis using anti-α-SMA antibody. Quantitative results of three immunoblots are
presented, where α-SMA protein levels are relative to that of GAPDH, which was used as loading control. The results are expressed as means ± SDs.
(C) Immunofluorescence analysis of control and Ct-infected HCjE cells with anti-α-SMA antibody (green fluorescence). Nuclei are stained with DAPI (blue fluorescence).
in a decrease in ACTA2 methylation, although to a lower extent
than in MSP analysis (from 15% in control to 11% in Ct-
infected cells) (Figures 8C–F). Bisulfite sequencing revealed that
the entire assayed region (except CpGs in primer sequences)
was completely unmethylated, without a difference in DNA
methylation between control and Ct-infected cells (data not
shown), indicating that MSP results give an adequate estimation
of the ACTA2 DNAmethylation level in the selected region.
DISCUSSION
The importance of EMT in trachomatous scarring has been
contemplated based on the finding that active trachoma is
associated with increased expression of profibrotic cytokines,
such as CTGF and IL-17A, which are known for their capability
to induce EMT (Burton et al., 2011). TGFβ is an archetypal
profibrotic molecule and the main EMT inducer; however, its
role in trachomatous scarring remains unresolved. Some studies
have reported constitutive expression of TGFβ proteins in the
conjunctiva, without any difference between trachoma cases
and controls (Burton et al., 2004; Derrick et al., 2016), while
others have reported stimulation of TGFβ1 in the conjunctiva of
trachoma patients (Bobo et al., 1996). We found that Ct infection
strongly induces mRNA expression of TGFβ, particularly TGFβ2,
in HCjE cells, in line with the finding that lung epithelial
cells show enhanced secretion of TGFβ after infection with Ct
(Williams et al., 1996). Viral infections of epithelial cells have also
been shown to result in increased TGFβ production (Dosanjh,
2006; Park et al., 2014), suggesting that induction of TGFβ
expression is a common response of epithelial cells to infection.
The inconsistency in TGFβ expression data in trachoma might
be explained by the presence or absence of infectious agents, as
active trachoma is associated with the concomitant inflammation
rather than Ct infection itself.
Besides the stimulation of TGFβ expression, infection of HCjE
cells with Ct triggered the activation of a multitude of signaling
pathways which are also, but not exclusively, downstream of
major EMT inducers. Activation of the PI3K pathway with
consecutive phosphorylation of AKT and its downstream target
BAD is involved in the mechanism protecting Ct-infected host
cells from apoptosis (Verbeke et al., 2006). MEK1/2 induction
with subsequent ERK1/2 activation is implicated in promoting
the acquisition of host phospholipids during the developmental
cycle of Ct in the host cell (Su et al., 2004). Activation of the
Wnt signaling pathway via GSK3β and subsequent sequestration
of β-catenin away from the junctional complexes to Ct inclusion
has been described in cervical epithelial cells infected with Ct
(Prozialeck et al., 2002). In summary, none of these pathways are
specific and exclusively related to EMT induction, but their joint
action leads to upregulation of EMT-related transcription factors
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FIGURE 5 | DNA Methylation Status of CDH1 after Infection with Ct. (A) Schematic representation of part of the E-cadherin gene CDH1 encompassing a CpG island.
The position of the TSS is marked as “+1,” while the positions of primers used for DNA methylation analysis and of CpG dinucleotides (short vertical lines) are shown
in the inset. M fw and M rev, methylated forward and reverse primers respectively; U fw and U rev, unmethylated forward and reverse primers, respectively. (B) Relative
levels of methylated products obtained after MSP analysis of CDH1 in control (C) and Ct-infected HCjE cells (Ct) compared to DNA methylated in vitro, assumed to be
100% methylated. The results are expressed as means ± SDs. (C–F) DNA methylation levels of the selected region obtained by HRM analysis. Representative aligned
melt curves (C) and difference plots (D) showing positions of C and Ct curves with respect to 0, 25, 50, and 100% methylated standards. (E) Standard curve, plot of
peak height versus percent of methylation (obtained as stated in the Materials and Methods section). (F) Bar graph depicting DNA methylation levels obtained from
standard curves for three samples of each of control (C) and Ct-infected HCjE cells (Ct). The results are expressed as means ± SDs.
and might induce EMT in HCjE cells. The EMT induced after
72 h of Ct infection was only partial, as morphological change of
HCjE cells was not observed.
The hallmark of the EMT process is a reduction in or loss of
expression of E-cadherin, which is a guardian of the epithelial
phenotype. We found decreases in mRNA and protein levels of
E-cadherin. At the same time, Ct infection induced α-SMA and
fibronectin expression, indicating that HCjE cells were moving
toward a mesenchymal phenotype. The rise in fibronectin
production is particularly significant, as it has been shown
that fibronectin acts as a potent EMT inducer. Epithelial cells
grown in the presence of fibronectin undergo spontaneous EMT
via the activation of integrin signaling and integrin-dependent
activation of endogenous latent TGFβ1 (Fontana et al., 2005;
Kim et al., 2006). Thus, the observed enhancement of fibronectin
production in Ct-infected HCjE cells might be an additional
trigger of the EMT process in HCjE cells. The capability of Ct
to induce changes in gene expression that are consistent with
EMT induction in conjunctival epithelial cells is in line with the
recent finding that Ct infection can induce EMT in reproductive
epithelial cells in vitro, as indicated by downregulation of the
epithelial markers E-cadherin and occludin and upregulation
of the mesenchymal markers SNAIL1/2, fibronectin, MMP9,
T-cadherin, and ZEB1 in these cells (Igietseme et al., 2015).
Additionally, the authors found evidence of EMT induction byCt
infection in vivo, linking trachomatous scarring in vivo to EMT
triggered by Ct infection.
Downregulation of E-cadherin expression is a highly complex
process that is carried out through DNA methylation of its
promoter and transcriptional repression (Strathdee, 2002). CpG
hypermethylation is associated with the recruitment of methyl-
CpG-binding proteins and consequent recruitment of histone
deacetylase enzymes, leading to histone H3 deacetylation and
E-cadherin transcriptional suppression (Koizume, 2002). We
analyzed the DNA methylation status of the well-defined CDH1
promoter subregion, the sequence located in close proximity
to the TSS, as it directly correlates with E-cadherin expression
(Reinhold et al., 2007). The increase in DNA methylation
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FIGURE 6 | Detailed DNA Methylation Status of a Selected Promoter Region of CDH1 after Infection with Ct Elucidated by Bisulfite Sequencing. (A,B) Schematic
representation of the methylation status of a selected promoter region in control (C) and Ct-infected HCjE cells (Ct) obtained by Sanger sequencing.
Bisulfite-converted DNA was subjected to PCR with methylated primers (shown in Figure 5A), and PCR products were sequenced using the corresponding forward
primers. (A) Lollipop diagram representing methylation status of the promoter region of CDH1 from four samples of each of C and Ct cells. The analyzed CpGs are
numbered 1 to 12, and their positions with regard to the TSS are indicated. White circles, unmethylated CpG; black circles, methylated CpG. (B) Representation of
combined DNA methylation data. Blue, unmethylated CpGs; yellow, methylated CpGs. (C) Positions and methylation status of CpGs in the context of regulatory
elements present in the promoter region of CDH1 (modified from van Roy and Berx, 2008).
from 12.8% in control cells to 21.8% after Ct infection
should be critically important for E-cadherin expression, as
it has been shown that a sharp decline in CDH1 expression
occurs above 15% of promoter methylation (Reinhold et al.,
2007). Bisulfite sequencing revealed that CpGs at positions
−57, −103, and −105 are fully methylated after Ct infection,
suggesting that those CpGs could be the first sites to be
methylated in response to infection with Ct and particularly
important for CDH1 expression because of their position
in the context of promoter-regulatory elements (Figure 6C).
Direct transcriptional control of E-cadherin has emerged as an
important regulatory mechanism in recent years. The CDH1
promoter region selected for analysis contains positive regulatory
elements as a CCAATmotive and two GC-rich boxes, recognized
by AP2 and SP1 transcription factors involved in basal E-
cadherin expression (Hennig et al., 1996; Faraldo et al., 1997).
One of the fully methylated CpGs (position −57) is part of a
GC-rich box, and its methylation could interfere with binding
of transcription factors and thus influence CDH1 transactivation.
The CDH1 promoter also contains negative regulatory E-
box elements required for active suppression of E-cadherin
expression (van Roy and Berx, 2008). E-cadherin suppression is
mediated by EMT-related transcription factors such as ZEB1/2,
TWIST, and SNAIL proteins (Thiery et al., 2009) through the
recruitment of various histone methyltransferases, deacetylases,
and demethylases, each responsible for a specific particular
histone modification (Serrano-Gomez et al., 2016). In addition,
it has been shown that SNAIL and ZEB1 cooperate with DNA
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FIGURE 7 | DNA Methylation Status of FN1 after Infection with Ct. (A) Schematic representation of parts of the fibronectin gene FN1 that encompass a CpG island.
The position of the TSS is marked as “+1,” while the positions of primers used for DNA methylation analysis and of CpG dinucleotides (short vertical lines) are shown
in the inset. M fw and M rev, methylated forward and reverse primers respectively; U fw and U rev, unmethylated forward and reverse primers, respectively. (B) Relative
levels of methylated products obtained after MSP analysis of FN1 in control (C) and Ct-infected HCjE cells (Ct) compared to DNA methylated in vitro, assumed to be
100% methylated. The results are expressed as means ± SDs. (C–F) DNA methylation levels of the selected region of FN1 obtained by HRM analysis. Representative
aligned melt curves (C) and difference plots (D) showing positions of C and Ct curves with respect to 0, 25, 50, and 100% methylated standards. (E) Standard curve,
plot of peak height versus percent of methylation (obtained as stated in the Materials and Methods section). (F) Bar graph depicting DNA methylation levels obtained
from standard curves for three samples of each of control (C) and Ct-infected HCjE cells (Ct). The results are expressed as means ± SDs.
methyltransferases (Lin et al., 2014; Fukagawa et al., 2015),
allowing in-site DNA methylation besides histone modifications.
This could be the immediate cause of the increased methylation
of CpGs adjacent to E-boxes that we observed in Ct-infected
cells. Together, our results implicate that DNAmethylationmight
be an additional mechanism contributing to transcriptional
repression of E-cadherin expression after Ct infection.
Although it is well accepted that DNA methylation of
the promoter region strongly correlates with transcriptional
repression, DNA methylation downstream of the TSS, in
particular of the first exon, is most critical for transcriptional
silencing, independently of the cell type (Brenet et al., 2011).
Highly methylated DNA sequences in the rat α-SMA gene
body correlated with its transcriptional suppression, while the
level of promoter methylation did not vary between α-SMA-
expressing and non-expressing cells (Hu et al., 2010). Therefore,
we selected sequences within the first exon for analysis of DNA
methylation of α-SMA and fibronectin. The results revealed a
decrease in the α-SMA methylation level after Ct infection of
4 or 10%, with the only methylated CpGs located within the
primer sequences. Thus, we cannot state that the decrease in gene
methylation significantly contributed to the observed increase in
mRNA and protein expression of α-SMA, at least with regard
to the selected region and time after Ct infection. Based on our
results, the augmentation of fibronectin expression on both the
mRNA and the protein level after Ct infection did not result
from the decrease in DNA methylation of the fibronectin gene.
Even though we found a slight decrease in DNA methylation of
3 and 4% after Ct infection in DNA methylation status using
MSP and HRM, respectively, bisulfite sequencing revealed that
the selected region was completely unmethylated. These results
are in agreement with a previous study investigating changes
in fibronectin expression levels in relation to DNA methylation
and histone acetylation (Kicic et al., 2010). By examining DNA
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FIGURE 8 | DNA Methylation Status of ACTA2 after Infection with Ct. (A) Schematic representation of parts of ACTA2, which encompasses a CpG island. The
position of the TSS is marked as “+1,” while the positions of primers used for DNA methylation analysis and of CpG dinucleotides (short vertical lines) are shown in the
inset. M fw and M rev, methylated forward and reverse primers respectively; U fw and U rev, unmethylated forward and reverse primers, respectively. (B) Relative levels
of methylated products obtained after MSP analysis of ACTA2 in control (C) and Ct-infected HCjE cells (Ct) compared to DNA methylated in vitro, assumed to be
100% methylated. The results are expressed as means ± SDs. (C–F) DNA methylation levels of ACTA2 selected region obtained by HRM analysis. Representative
aligned melt curves (C) and difference plots (D) showing positions of C and Ct curves with respect to 0, 25, 50, and 100% methylated standards. (E) Standard curve,
plot of peak height vs. percent of methylation (obtained as stated in the Materials and Methods section). (F) Bar graph depicting DNA methylation levels obtained from
standard curves for three samples of each of control (C) and Ct-infected HCjE cells (Ct). The results are expressed as means ± SDs.
methylation in two CpG islands upstream and downstream of
TSS, the authors found no evidence of DNA methylation in
circumstances of low fibronectin expression (Kicic et al., 2010).
Our results indicate that EMT could be an additional
underlying mechanism of fibrotic processes in trachoma. Using
an in vitro model of conjunctival Ct infection over 72 h,
we could detect the earliest EMT-related events, such as
activation of EMT-related signaling pathways, followed by up-
and down-regulation of specific EMT markers. However, within
the observed timeframe of 72 h, complete transition toward
a fibrotic phenotype, including morphological changes, were
not observed in the applied in vitro model. Thus, an in
vitro experiment with long-term antibiotics treatment of HCjE
cells, 72 h post Ct infection, will be conducted to prolong
the lifespan of the cells and open a timeframe for analysis
of induced phenotypic changes and their transgenerational
transmission. Furthermore, additional in vivo studies are
needed to unequivocally confirm the involvement of EMT in
trachomatous scarring. However, this study presents a solid
foundation for further functional analysis of DNA methylation
during Ct infection, given that the results presented here
are the first, to our knowledge, to link Ct infection with
modulation of host DNA methylation status. A genome-wide
DNA methylation study revealed that infection with another
bacterium from the genus Chlamydia, Chlamydia psittaci,
might be responsible for 180 differentially methylated genes in
patients with ocular adnexal extranodal marginal zone B-cell
lymphoma (EMZL) (Lee et al., 2014). Moreover, Ct produces
NUE methyltransferase, which is able to methylate mammalian
histones (Pennini et al., 2010), and alters the expression of crucial
miRNAs that control EMT and fibrosis (Igietseme et al., 2015).
Additionally, differential expression of several miRNAs has been
described in trachoma patients (Derrick et al., 2013, 2016). Taken
together, the data point to a straightforward link between Ct
infection and a spectrum of epigenetic changes in the host
cell.
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If confirmed, our finding that Ct infection might induce
EMT in host cells through DNA methylation changes could
play a particularly important role in the development of new
therapeutic approaches to trachoma treatment, based on the
reversibility of both processes of EMT and DNA methylation.
Targeting Ct-induced EMT by demethylating agents, such as
the DNA methyltransferase inhibitor azacitidine, might have
significant therapeutic potential. However, the main obstacle
of epigenetic drugs is their complex network of functions and
concomitant variety of side effects associated with systemic
application. This could be avoided using gene editing by targeted
DNA demethylation and activation of the E-cadherin gene
that is essential for maintaining epithelial cell identity. This
approach seems as a promising methodology for use in trachoma
treatment, as it would potentially enable reversing or at least
stopping scar progression in ocular Ct infection.
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